ReviewFrontiers in genetics2026
Short CAG repeat variation as a regulatory factor in health and disease.
Review in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Short cytosine-adenine-guanine (CAG) trinucleotide repeats, which encode polyglutamine (polyQ) tracts, are prevalent features of genes enriched in transcriptional and regulatory functions, including the androgen receptor (AR) and huntingtin (HTT). While expanded CAG repeats are well established in neurodegenerative disease pathogenesis, the functional significance of short, non-pathogenic repeat lengths remains underappreciated. This review connects evidence demonstrating that short CAG/polyQ tracts act as dynamic modulators of protein conformation, transcriptional activity, and protein-protein interactions. Variation within physiological repeat ranges influences receptor sensitivity, cellular signaling, and phenotypic diversity. The AR serves as a central model, where shorter repeat lengths enhance transactivation and androgen responsiveness and are associated with increased prostate cancer risk, while longer non-expanded repeats are linked to reduced receptor activity and modest reproductive and metabolic effects. Mechanistically, repeat length and sequence composition jointly influence repeat stability, RNA structure, and downstream regulatory processes. Beyond AR, short CAG variation contributes to neuropsychiatric phenotypes and broader regulatory networks. Collectively, short CAG repeats function as quantitative regulators of gene activity, shaping disease susceptibility, physiological variation, and evolutionary adaptation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.